Braquiterapia de alta tasa de dosis con Iridio 192 en el manejo conservador del cáncer de mama. Experiencia del Hospital Central Militar

Contenido principal del artículo

Rafael de la Huerta Sánchez

Resumen

Demostrar que la braquiterapia es cada vez más empleada en pacientes con cáncer mamario, con el propósito de preservar la glándula mamaria.

Detalles del artículo

Sección

Artículos de investigación

Cómo citar

1.
Braquiterapia de alta tasa de dosis con Iridio 192 en el manejo conservador del cáncer de mama. Experiencia del Hospital Central Militar. RSM [Internet]. 2024 Oct. 8 [cited 2026 Feb. 4];59(5). Available from: https://www.revistasanidadmilitar.org/index.php/rsm/article/view/1884

Referencias

White JA, Wilson JF. Brachytherapy and breast cancer. Sem Surg Oncol 1997; 13: 190-5.

Keynes G. The treatment of primary carcinoma of the breast with radium. Acta Radiol 1929; 10: 393-402.

Harris JR, Botnick L, Bloomer WD, et al. Primary radiationtherapy for early breast cancer: the experience at the joint center for radiation therapy. Int J Radiat Oncol Biol Phys 1981; 7: 1549-52.

Touboul E, Buffat L, Lefrane JP, et al. Possibility of conservative local treatment after combined chemotherapy and preoperative irradia- tion for locally advanced no inflammatory breast cancer. Int J Radiat Oncol Biol Phys 1996; 34: 1019-28.

Sedlmayer F, Rahim HB, Kogelnik HD, et al. Quality assurance in breast cancer brachytherapy: geographic miss in the interstitial bo- ost treatment of the tumor bed. Int J Radiat Oncol Biol Phys 1996; 1133-9.

Polgar C, Major T, Fodor J, et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor ed boost after breast conserving surgery: seven year results of a comparative study. Int J Radiat Oncol Biol Phys 2004; 60(4): 1173-81.

AJCC 2002.

Thomas F, Arriagada H, Mouriesse H, et al. Radical radiotherapy alone in non-operable breast cancer: The major impact of tumor size and histological grade on prognosis. Radiother Oncol 1988; 13: 267-76.

Valagussa P, Zambetti M, Bignami P, et al. Advaced breast cancer. Clin Exp Metastasis 1983; 1: 191-202.

Shah WM, Wazer DE. The mammosite ballon brachytherapy ca- theter for accelerated breast irradiation. Sem Radiat Oncol 2005; 15:

-7.

Richards GM, Berson AM, Rescigno J, et al. Acute toxicity of high dose rate intracavitary brachytherapy with the mammsosite applica- tor in patients with early stage breast cancer. Ann Surg Oncol 2004; 11(8): 739-46.

Póti Z, Neméskeri C, Ferésházy A, et al. Partial breats irradiation with interstitial Co 60 brachytherapy results in frequent grade 3 or 4 toxi- city, evidence based on a 12 year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 2004; 58(4): 1022-33.

Margolis GJ, Carabel SC, Goodman RL. Psychological aspects of primary radiation therapy for breast carcinoma. Am J Clin Oncol 1983;

(5): 533-8.

Pierquin B, Chassagne DJ, Chahbazian CHM, et al. Brachythera- py. St Louis Warren H. Green Inc 1979.

De la Huerta-Sánchez R, Bustos-Trejo M, Delgado-Gallardo S, et al. Tratamiento conservador de la glándula mamaria con radioterapia externa e implante de Iridio-192 en carcinoma mamario etapa clínica III. Cancerología 1988; 34(3): 609-16.

Artículos más leídos del mismo autor/a